申请人:Council of Scientific & Industrial Research
公开号:US08309726B2
公开(公告)日:2012-11-13
The present invention provides novel anthranilic acid derivative useful as potential anticancer agent. More particularly, the present invention relates novel anthranilic acid derivative of general formula (8), R′=alkyl-2-methoxyphenyl piperazine or benzyl; R=2-methoxyphenyl, piperazine, 2-pyridyl piperazine-1-yl, 2-pyrimidyl piperazine-1-yl, 4-quinazolinyl piperazine-1-yl, 9H-9-fluorenylamine, 4-(2amino-5-(methoxy)-4-[(phenylmethyl)oxy]phenyl}carbonyl)-hexahydro-1-pyrazinyl], and [(4[2-amino-4-(benzyloxy)-5-methoxybenzoyl]aminophenyl)-sulfonyl]-4-benzamine; X═H or pyrazine-2-carbonyl. The present invention also provides a process for the preparation of novel anthranilic acid derivative of general formula (8), which is useful as potential anticancer agent.
本发明提供了一种新型的蒽酸衍生物,可用作潜在的抗癌剂。更具体地说,本发明涉及一般式(8)的新型蒽酸衍生物,其中R′=烷基-2-甲氧基苯基哌嗪或苄基;R=2-甲氧基苯基、哌嗪、2-吡啶基哌嗪-1-基、2-嘧啶基哌嗪-1-基、4-喹唑啉基哌嗪-1-基、9H-9-芴胺、4-(2-[氨基-5-(甲氧基)-4-[(苯甲基)氧基]苯基]甲酰基)-六氢-1-吡嗪基}和[(4-[2-氨基-4-(苄氧基)-5-甲氧基苯甲酰基]氨基苯基)-磺酰基]-4-苯胺;X=H或吡嗪-2-羰基。本发明还提供了一种制备上述新型蒽酸衍生物的方法,该方法可用作潜在的抗癌剂。